NAD+ Injection 1000 mg

NAD+ Injection 1000 mg/Vial is a high-strength sterile injectable formulation containing Nicotinamide Adenine Dinucleotide (NAD+), an essential endogenous coenzyme involved in fundamental cellular biochemical processes. This product is positioned for regulated pharmaceutical supply chains and institutional use only. AmeriDrugs supplies this product strictly for export to licensed international buyers and does not engage in consumer-level distribution.

Active Ingredient

• Nicotinamide Adenine Dinucleotide (NAD+) – 1000 mg per vial
  NAD+ functions as a critical coenzyme in oxidation-reduction reactions and cellular energy metabolism pathways at the molecular level.

Therapeutic Use
In professional and regulatory contexts, NAD+ injectable formulations are supplied to authorized healthcare institutions and pharmaceutical distributors for use under approved medical, clinical, or research frameworks, depending on local regulations. This information is provided for product identification and trade clarity only. AmeriDrugs does not offer medical advice, treatment claims, or patient-directed usage guidance.

Dosage Form

• Sterile injectable solution

• Supplied in single-dose pharmaceutical-grade glass vials

• Route and method of administration are determined exclusively by qualified healthcare professionals in compliance with applicable regulatory standards

Quality & Manufacturing Standards
NAD+ Injection 1000 mg/Vial is produced in GMP-compliant manufacturing facilities adhering to internationally accepted quality systems such as WHO-GMP or equivalent standards. Each batch undergoes stringent quality control procedures, including sterility, potency, and stability testing, to meet global export and regulatory expectations.

Packaging Information

• Secure amber glass vial with rubber stopper and aluminum seal

• Export-appropriate secondary packaging to protect product quality during storage and international logistics

• Packaging options may be customized according to importer specifications and regulatory requirements

Target Buyers
This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and wholesalers

• Hospitals, clinics, and institutional healthcare providers

• Government tenders and authorized procurement agencies

• Approved research and clinical supply organizations

Retail sale and direct consumer distribution are strictly excluded.

Regulatory & Compliance Note
NAD+ Injection 1000 mg/Vial is a prescription-only injectable pharmaceutical product. Importation, distribution, and utilization must comply with the drug regulations, licensing requirements, and approval processes of the destination country. Buyers are responsible for ensuring regulatory compliance within their jurisdiction. AmeriDrugs operates solely as an export-oriented pharmaceutical supplier and does not promote this product for self-medication or non-regulated use.